Teza Capital Management LLC Penumbra Inc Transaction History

Teza Capital Management LLC

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 14, 2024	BUY	$181.44 - $260.22 $488,617 - $700,772	2,693 New	2,693 $677,000
Q2 2023 Feb 22, 2024	SELL	$271.54 - $344.06 $93,681 - $118,700	-345 Reduced 35.03%	640 $220,000
Q2 2023 Aug 14, 2023	SELL	$271.54 - $344.06 $243,299 - $308,277	-896 Reduced 36.48%	1,560 $536,000
Q1 2023 Feb 22, 2024	SELL	$220.43 - $278.69 $376,494 - $476,002	-1,708 Reduced 63.42%	985 $274,000
Q1 2023 May 15, 2023	BUY	$220.43 - $278.69 $149,010 - $188,394	676 Added 37.98%	2,456 $684,000
Q4 2022 Feb 14, 2023	BUY	$151.88 - $228.5 $270,346 - $406,730	1,780 New	1,780 $395,000
Q1 2020 May 11, 2020	SELL	$124.34 - $193.76 $310,725 - $484,206	-2,499 Closed	0 $0
Q4 2019 Feb 12, 2020	BUY	$134.81 - $177.8 $336,890 - $444,322	2,499 New	2,499 $411,000
Q3 2019 Nov 12, 2019	SELL	$131.82 - $183.4 $200,498 - $278,951	-1,521 Closed	0 $0
Q2 2019 Aug 08, 2019	BUY	$124.65 - $167.39 $189,592 - $254,600	1,521 New	1,521 $243,000

370

29.1M

220K

158K

Ticker PEN
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 37,888,400
Market Cap $9.01B
Description
Penumbra, Inc. designs, develops, manufactures, and markets medical devices in the United States and internationally. The company offers aspiration based thrombectomy systems and accessory devices, including revascularization device for mechanical thrombectomy, such as Penumbra System under the Penumbra RED, JET, ACE, 3D Revascularization Device...

Get notified when there are updates to the investment portfolio of Teza Capital Management LLC, based on Form 13F filings with the SEC.

Stay updated on Teza Capital Management LLC with notifications on news.